Amy Mahery
About Amy Mahery
Amy Mahery serves as the Chief Commercial Officer at Roivant Sciences, a position she has held since 2022. With over twenty years of experience in the biopharmaceutical industry, she previously led global market access and pricing at EMD Serono for eighteen years.
Work at Roivant Sciences
Amy Mahery has served as the Chief Commercial Officer at Roivant Sciences since 2022. In this role, she oversees commercial strategy and execution, focusing on enhancing market access and patient access across the company's portfolio. Her leadership is integral to driving growth and ensuring that Roivant's innovative therapies reach the patients who need them.
Previous Experience at EMD Serono
Prior to joining Roivant Sciences, Amy Mahery worked at EMD Serono, Inc. for 18 years, where she held the position of Senior Vice President and Head of the Global Business Franchise for Neurology and Immunology. During her tenure, she led the Global Market Access and Pricing team, which aimed to expand access for all product franchises worldwide. She developed strategies that facilitated growth across multibillion-dollar product portfolios.
Career at Johnson & Johnson
Before her extensive career at EMD Serono, Amy Mahery worked at Johnson & Johnson (McNeil Specialty) as a Senior Sales Training Specialist from 1999 to 2004. In this role, she contributed to the training and development of sales teams, enhancing their effectiveness in the marketplace.
Education and Expertise
Amy Mahery holds a B.S. in Neuroscience from Trinity College-Hartford, where she studied from 1995 to 1999. She also pursued Executive Education at INSEAD and Stanford University, further enhancing her expertise in the biopharmaceutical field. Her educational background supports her extensive experience in commercial leadership roles within the industry.
Leadership and Community Involvement
Amy Mahery has demonstrated a commitment to leadership development and diversity in the workplace. She founded the Community Outreach Program at EMD Serono to expand leadership opportunities for women. Additionally, she served as the healthcare representative on Merck KGaA’s group-level Diversity Council and is a member of the Boston Consulting Group’s Market Access Roundtable, contributing to discussions on market access strategies.